Literature DB >> 10716720

Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.

R B Halberg1, D S Katzung, P D Hoff, A R Moser, C E Cole, R A Lubet, L A Donehower, R F Jacoby, W F Dove.   

Abstract

The interaction between mutations in the tumor-suppressor genes Apc and p53 was studied in congenic mouse strains to minimize the influence of polymorphic modifiers. The multiplicity and invasiveness of intestinal adenomas of Apc(Min/+) (Min) mice was enhanced by deficiency for p53. In addition, the occurrence of desmoid fibromas was strongly enhanced by p53 deficiency. The genetic modifier Mom1 and the pharmacological agents piroxicam and difluoromethylornithine each reduced intestinal adenoma multiplicity in the absence of p53 function. Mom1 showed no influence on the development of desmoid fibromas, whereas the combination of piroxicam and difluoromethylornithine exerted a moderate effect. The ensemble of tumor suppressors and modifiers of a neoplastic process can be usefully analyzed in respect to tissue specificity and synergy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716720      PMCID: PMC16262          DOI: 10.1073/pnas.97.7.3461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Identification and classification of p53-regulated genes.

Authors:  J Yu; L Zhang; P M Hwang; C Rago; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 2.  Familial polyposis coli.

Authors:  S Bülow
Journal:  Dan Med Bull       Date:  1987-03

Review 3.  The adenomatous polyposis coli gene of the mouse in development and neoplasia.

Authors:  W F Dove; C Luongo; C S Connelly; K A Gould; A R Shoemaker; A R Moser; R L Gardner
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

4.  Retinoblastoma: a prototypic hereditary neoplasm.

Authors:  A G Knudson
Journal:  Semin Oncol       Date:  1978-03       Impact factor: 4.929

5.  Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine requires p53.

Authors:  S Narayan; A S Jaiswal
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice.

Authors:  K A Gould; W F Dietrich; N Borenstein; E S Lander; W F Dove
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

7.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 8.  The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics.

Authors:  L C Strong; W R Williams; M A Tainsky
Journal:  Am J Epidemiol       Date:  1992-01-15       Impact factor: 4.897

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice.

Authors:  M Harvey; H Vogel; D Morris; A Bradley; A Bernstein; L A Donehower
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

View more
  57 in total

1.  Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.

Authors:  Jamie N Hadac; Alyssa A Leystra; Terrah J Paul Olson; Molly E Maher; Susan N Payne; Alexander E Yueh; Alexander R Schwartz; Dawn M Albrecht; Linda Clipson; Cheri A Pasch; Kristina A Matkowskyj; Richard B Halberg; Dustin A Deming
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Tumor suppression and normal aging in mice with constitutively high p53 activity.

Authors:  Susan M Mendrysa; Kathleen A O'Leary; Matthew K McElwee; Jennifer Michalowski; Robert N Eisenman; Douglas A Powell; Mary Ellen Perry
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

3.  Daikenchuto (TU-100) Suppresses Tumor Development in the Azoxymethane and APCmin/+ Mouse Models of Experimental Colon Cancer.

Authors:  Takumu Hasebe; Jun Matsukawa; Daina Ringus; Jun Miyoshi; John Hart; Atsushi Kaneko; Masahiro Yamamoto; Toru Kono; Mikihiro Fujiya; Yutaka Kohgo; Chong-Zi Wang; Chun-Su Yuan; Marc Bissonnette; Mark W Musch; Eugene B Chang
Journal:  Phytother Res       Date:  2016-10-12       Impact factor: 5.878

Review 4.  Corruption of homeostatic mechanisms in the guanylyl cyclase C signaling pathway underlying colorectal tumorigenesis.

Authors:  Peng Li; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2010-08-11       Impact factor: 4.742

5.  Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness.

Authors:  Stephen H Tsang; Michael L Woodruff; Lin Jun; Vinit Mahajan; Clyde K Yamashita; Robert Pedersen; Chyuan-Sheng Lin; Stephen P Goff; Thomas Rosenberg; Michael Larsen; Debora B Farber; Steven Nusinowitz
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

Review 6.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

Review 7.  Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.

Authors:  Eugene W Gerner; Elizabeth Bruckheimer; Alfred Cohen
Journal:  J Biol Chem       Date:  2018-10-24       Impact factor: 5.157

8.  PUMA suppresses intestinal tumorigenesis in mice.

Authors:  Wei Qiu; Eleanor B Carson-Walter; Shih Fan Kuan; Lin Zhang; Jian Yu
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

Review 9.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

10.  Clusterin as a biomarker in murine and human intestinal neoplasia.

Authors:  Xiaodi Chen; Richard B Halberg; William M Ehrhardt; Jose Torrealba; William F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.